MLICM
WGS icon

Metropolitan Life Insurance Company (MetLife)’s GeneDx Holdings WGS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-327
Closed -$13.6K – 2362
2022
Q2 		$13.6K Buy
+327
New +$22.2K ﹤0.01% 2228

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s WGS Position: Q3 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of GeneDx Holdings (WGS) in Q3 2022, closing a stake of 327 shares — an estimated $13.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in WGS in Q2 2022 and held it in 1 quarter. The position peaked at $13.6K in Q2 2022. 98 funds tracked by Wall St. Rank hold WGS as of Q3 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining GeneDx Holdings position as of Q3 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 327 GeneDx Holdings shares in Q3 2022, an estimated $13.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in GeneDx Holdings in Q2 2022 and held it in 1 quarter.
  • Metropolitan Life Insurance Company (MetLife)'s GeneDx Holdings position peaked at $13.6K in Q2 2022.
  • 98 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.